BRule_Final_Resume_v1
- 1. BRITTNY ANN RULE, PHARM.D., M.B.A., R.PH. 119 Vista Drive, Cedar Knolls, NJ 07927 570.406.1465 | brittny.rule@gmail.com PROFESSIONAL EXPERIENCE BAYER HEALTHCARE PHARMACEUTICALS, U.S. Whippany, NJ Rutgers Institute for PharmaceuticalIndustry Fellowships 07/2014 - Present Postdoctoral Fellow, Hematology BusinessUnit Kovaltry Brand Marketing/Product Launch Manager, US Hematology Marketing 01/2015 - Present Leads the cross-functional US Launch Readiness team responsible for activity prioritization, tracking, and reporting for the launch of a new hemophilia product Secures alignment on key launch messaging across Medical, Marketing, and LMR (legal, medical, regulatory) teams in order to provide guidance to all HCP and patient promotional messages Drives creative development and execution of Coming Soon and Now Available campaigns through non-personal, digital e-marketing tactics,and presence at conventions and congresses (ASH,NHF, HFA) Maximizes brand awareness efforts by direct to consumer promotional Kovaltry tactics, including efforts targeting Hispanic/Spanish communities Gains customer insights by managing and overseeing advisory boards for multidisciplinary audiences (caregivers, social workers, advocacy), nurses,and healthcare providers in hemophilia Drives creative development and execution of all Package Insert based (PI-based) promotional tactics at launch for field sales teams Oversee, maintain, and liaise with the creative, brand-team marketing agencies to ensure prioritization of launch projects and execution in alignment with launch strategy Collaborates with Kovaltry global marketing teams to ensure alignment with US messaging and supporting tactics Medical Affairs/Medical Communications, US Hematology 07/2014 - 01/2015 Created enhancements to effectively and innovatively communicate Bayers Hematology pipeline through convention presences (NHF,ASH,ASPHO,HTRS) and non-personal communications Proactive participation and involvement on pre-launch activities for, BAY 81-8973 including: preparing package insert for BLA submission, development of training materials, identification of frequently asked questions (FAQs),objection handling and preparing medical content letters Served as active member of various committees as needed (e.g. publications planning committee, pre-launch clinical meetings, advertising/promotional review) Served as a hematology medical information/clinical expert related to products and pipeline assets to internal cross-functional team members and external stakeholders CVS PHARMACY Livingston, NJ Part-Time Pharmacist 08/2014 Present Pharmacy Intern/Technician 08/2006 07/2014 Delivers optimal customer service to patients, including patient counseling, teaching techniques of devices, ensuring literacy of medication use Leads pharmacy teams to advance CVSs initiatives, missions, and values through patient adherence programs and collaboration with other key healthcare professionals Serves as a medication expert to patents and HCPs on prescription products, approved label dosing, over the counter (OTC) medications, indications, efficacy ELI LILLY AND COMPANY Indianapolis, IN Managed Health Services 09/2013 - 11/2013 Developed strategies to address key government segments such as Medicare Part D and Medicaid, as well other dynamics of the government payer marketplace Served as internal expert of government programs, such as Patient Centered Medical Homes (PCMH), Accountable Care Organizations (ACOs),Affordable Care Act (ACA)
- 2. 2 EDUCATION Rutgers University - School ofPublic Health Masters of Public Health, Quantitative Methods in Biostatistics and Epidemiology 2014 2016 Wilkes University - Jay S. Sidhu School ofBusiness and Leadership Masters of Business Administration 2012 2014 Wilkes University - Nesbitt College ofPharmacy & School ofNursing Doctor of Pharmacy 2008 - 2014 PHARMACEUTICALJOURNAL PUBLICATIONS Srikonda A, Rule B,ToscaniM, Adams C, Brunetti L .Selecting a Target Specific Anticoagulant in the Geriatric Patient with Nonvalvular Atrial Fibrillation. Journal of Clinical Outcome Management,Dec 2015. Bommareddy A, Rule B, VanWert AL,Santha S and Dwivedi C. Alpha-santalol, a chemopreventive agent induces apoptosis in human prostate cancer cells by causing caspase-3 activation. Phytomedicene,19: 804-811, 2012. Santha S, Bommareddy A, Rule B, Guillermo R, Kaushik RS, Young A, Dwivedi C. Antineoplastic effects of 留- santalol on estrogen receptor-positive and estrogen receptor- negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis. PLoS 8(2): e56982. 2013. PHARMACEUTICALPUBLISHED ABSTRACTS Ajay Bommareddy, Brittny Rule,Adam VanWert,Sreevidya Santha, Chandradhar Dwivedi. Alpha-santalol, a chemopreventive agent induces apoptosis in human prostate cancer cells by causing caspase-3 activation. American Association for Cancer Research (AACR) conference,Chicago, IL (April 2012). Hiral Patel,Aleona Chinikaylo, Michelle Wakeley, Brittany Lippert, Valerie Kalter, Brittny Rule,Bethany Eiche, Zenaida Lopez-Dee,Ajay Bommareddy, Linda Gutierrez. Evidence for a mechanistic link between thrombospondin 1 and Lgr5 in a model of colitis-associated carcinogenesis. Crohns and colitis foundations clinical and research conference,Hollywood, FL (December 2011). Ajay Bommareddy, Brittny Rule,Bethany Sharpless, Lauren Machell, Lindsey Coval, Sreevidya Santha, Chandradhar Dwivedi. Anticancer effects of alpha-santalol on prostate cancer development. Annual AACP conference,San Antonio, TX (July 2011). LICENSURES/CERTIFICATIONS New Jersey Pharmacist 28RI03643600 New Jersey Immunization Approval 28RJ05806 Pennsylvania Pharmacist RP448724 Pennsylvania Authorization to Administer Injectable RPI008613